FIELD: organic chemistry. SUBSTANCE: invention describes novel compounds of the general formula (I) where X means S, O; X means [C(R1)2]n where n = 0-2; R1 means independently H or alkyl with 1-6 carbon atoms; R2 means hydrogen atom or lower alkyl with 1-6 carbon atoms; R3 means hydrogen atom or lower alkyl with 1-6 carbon atoms; m = 0-2; o = 0-4; p = 0-2; r = 0-2 under condition that when Z means O then sum of p means at least 1 and r means at least 1 and (W)p is not a single alkyl group; Y means phenyl or pyridyl groups that may have one or two groups R2 as a substituent; W means a substituent taken among the group consisting of F, Br, Cl, J, C1-6-alkyl, fluorine-substituted C1-6-alkyl, NO2, N3, OH, OCH2OCH3; L means -(C= Z)-NH- or HN-(C=Z); Z means O or S; A means (CH2)q where q = 0-5; B means COOH or its pharmaceutically acceptable salt, COOR8 where R8 means alkyl group with 1-10 carbon atoms. Compounds of the formula (I) show retinoid-like biological activity. EFFECT: valuable biological activity. 30 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHODS OF THERAPY BY APPLYING THE COMPOUNDS EITHER OF SPECIFIC OR SELECTIVE ACTIVITY TO RETINAL ACID RECEPTOR RAR | 1996 |
|
RU2191009C2 |
BIPHENYL DERIVATIVES AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS COMPRISING THEREOF | 1998 |
|
RU2193552C2 |
BIAROMATIC COMPOUNDS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON THEREOF | 1998 |
|
RU2185373C2 |
HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF 5-LIPOXYGENASE ACTIVITY | 1995 |
|
RU2136666C1 |
APOPTOSIS INDUCING AGENTS FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES | 2011 |
|
RU2568611C2 |
3-CARBOXYPROPYL-AMINOTETRALINE DERIVATIVES AND RELATED COMPOUNDS AS MU-OPIOID RECEPTOR ANTAGONISTS | 2008 |
|
RU2482107C2 |
5-HETEROCYCLO-1,5-BENZODIAZEPINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1995 |
|
RU2152939C1 |
SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS, METHODS OF PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE AGENT | 2014 |
|
RU2654483C2 |
2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
Authors
Dates
2001-03-10—Published
1996-11-18—Filed